about
HIV model parameter estimates from interruption trial data including drug efficacy and reservoir dynamicsLong-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cellsOptimal antiviral switching to minimize resistance risk in HIV therapy.Robust closed-loop minimal sampling method for HIV therapy switching strategies.Modelling HIV-1 2-LTR dynamics following raltegravir intensification.Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification.Increased inflammation in sanctuary sites may explain viral blips in HIV infection.Using the Tools we Have: Low-efficacy Vaccines and HIV.Modeling uncertainty in single-copy assays for HIV.Closed-loop minimal sampling method for determining viral-load minima during switching.Model-driven approaches for in vitro combination therapy using ONYX-015 replicating oncolytic adenovirus.Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence.Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence.Order preservation of expected information content using Unscented Transform approximation of multivariate prior distributions in HIV 2-LTR experiment design.Experiment Design for Early Molecular Events in HIV Infection.Implications of Measurement Assay Type in Design of HIV Experiments.Synaptic transmission may provide an evolutionary benefit to HIV through modulation of latencyHIV 2-LTR experiment design optimization
P50
Q28481343-EACC30F6-D8E6-425C-A3A4-A49CE69C8757Q34059612-A54CA3D7-FA50-4769-8691-FB42851A16B4Q34071754-1E9B4271-3619-498F-BCF1-4BA8BECC21D1Q36306340-2CEED1E2-4504-4029-9EE1-D026D06474D7Q36904249-A810268F-1051-438B-8709-BC176E88585DQ37621893-BC676BC5-5C34-4E86-9EA0-6A4E1D511C7EQ40604582-7B94B157-F80A-4247-A095-AE59382B9B6BQ40805936-0572B693-2715-499B-9935-DEE41D83E244Q42201743-E8FFB443-D2BE-4233-99DC-77368F198748Q42414791-CE29E530-E729-4B0D-9B88-BF2DE5FF2FF2Q42544861-D952212B-9E01-400A-88F6-B9FBC9BB05E5Q47301054-9B431DCD-5CD6-4B4F-83FF-C9F109272ACCQ47548203-5EB0CA5F-FD43-4C54-BC2A-35073D2A7D7CQ49425434-D1DB19FD-0A4E-4539-8099-911FB8EFA556Q49674917-E98734F5-D4ED-48B9-A7A9-B48B0321822CQ50042023-13B57993-6EA2-4370-86E7-E02486C2C706Q57467563-C64CF88A-E3B8-4BA4-9A13-BF4F2BAB7D06Q58588408-DD0C5ECA-689E-4634-91F0-3A3CD5A6CE1E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ryan Zurakowski
@ast
Ryan Zurakowski
@en
Ryan Zurakowski
@es
Ryan Zurakowski
@nl
Ryan Zurakowski
@sl
type
label
Ryan Zurakowski
@ast
Ryan Zurakowski
@en
Ryan Zurakowski
@es
Ryan Zurakowski
@nl
Ryan Zurakowski
@sl
prefLabel
Ryan Zurakowski
@ast
Ryan Zurakowski
@en
Ryan Zurakowski
@es
Ryan Zurakowski
@nl
Ryan Zurakowski
@sl
P106
P1153
6508290029
P21
P31
P496
0000-0003-3726-3114